Endothelin and endothelin antagonists: Potential role in cardiovascular and renal disease

Molecular and Cellular Biochemistry

Volumn 157, Issue 1-2, 1996, Pages 259-267

  Noll, G ^a   Wenzel, R R ^a   Luscher T F ^a,b  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Endothelin; Endothelin receptor antagonist; Endothelium

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; CYCLOSPORIN; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; MITOGENIC AGENT; NITRIC OXIDE; PROSTACYCLIN; TACROLIMUS; THROMBIN; TRANSFORMING GROWTH FACTOR BETA;

ARTERIOSCLEROSIS; ARTICLE; CELL PROLIFERATION; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; GRAFT VERSUS HOST REACTION; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; HYPOXIA; ISCHEMIA; KIDNEY DISEASE; KIDNEY FAILURE; MIGRAINE; PULMONARY HYPERTENSION; RECEPTOR BLOCKING; SMOOTH MUSCLE CONTRACTION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 0029937979     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00227908     Document Type: Article

References (105)

1. Lüscher TF, Boulanger CM, Dohi Y, Yang ZH: Endothelium-derived contracting factors. Hypertension 19: 117-130, 1992
2. Lüscher TF, Seo BG, Bühler FR: Potential role of endothelin in hypertension: Controversy of endothelin in hypertension. Hypertension 21: 752-757, 1993
3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
4. Kiowski W, Lüscher TF, Linder L, Bühler FR: Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endotheliumderived relaxing factor. Circulation 83: 469-475, 1991
5. Simonson MS, Wann S, Mene P, Dubyak GR, Kester M, Nakazato Y, Sedor JR, Dunn MJ: Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83: 708-712, 1989
6. Takuwa N, Takuwa Y, Yanagisawa M, Yamashita K, Masaki T: A novel vasoactive peptide endothelin stimulates mctogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 264: 7856-7861, 1989
7. Hirata Y, Takagi Y, Fukuda Y, Marumo F: Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78: 225-228, 1989
8. Goerre S, Wenk M, Bärtsch P, Lüscher TF, Niroomand S, Hohenhaus E, Oelz O, Reinhart WH: Endothelin-1 in Pulmonary Hypertension associated with High Altitude. Circulation 90: 359-364, 1994
9. Rakugi H, Tabuchi Y, Nakamaru M, Nagano M, Higashimori K, Mikami H, Ogihara T, Suzuki N: Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun 169: 973-977, 1990
10. Boulanger CM, Lüscher TF: Hirudin and nitrates inhibit the thrombin-induced release of endothelin from the intact porcine aorta. Circ Res 68: 1768-1772, 1991
11. Rosolowsky LJ, Campbell WB: Endothelin enhances adrenocorticotropin-stimulated aldosterone release from cultured bovine adrenal cells. Endocrinology 126: 1860-1866, 1990
12. Goetz KL, Wang BC, Madwed JB, Zhu JL, Leadley R, Jr.: Cardiovascular renal and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 255: R1064-1068, 1988
13. Boulanger C, Lüscher TF: Release of endothelin from the porcine aorta. Inhibition of endothelium-derived nitric oxide. J Clin Invest 85: 587-590, 1990
14. Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe TX, Sakakibara S, Goto K, Masaki T: Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85: 6964-6967, 1988
15. Dohi Y, Hahn AW, Boulanger CM, Bühler FR, Lüscher TF: Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 19: 131-137, 1992
16. Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F: Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension 18: 165-170, 1991
17. Hattori Y, Kasai K, Nakamura T, Emoto T, Shimoda S: Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism 40: 165-169, 1991
18. Endo T, Uchida Y, Matsumoto H, Suzuki N, Nomura A, Hirata F, Hasegawa S: Regulation of endothelin-1 synthesis in cultured guinea pig airway epithelial cells by various cytokines. Biochem Biophys Res Commun 186: 1594-1599, 1992
19. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T: Release of immunoreactive endothelin from porcine aortic strips. Hypertension 15: 718-723, 1990
20. Yoshizumi M, Kurihara H, Morita T, Yamashita T, Oh-hashi Y, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y: Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 166: 324-329, 1990
21. Yamashita J, Ogawa M, Nomura K, Matsuo S, Inada K, Yamashita S, Nakashima Y, Saishoji T, Takano S, Fujita S: Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells. Cancer Res 53: 464-467, 1993
22. Saijonmaa O, Ristimaki A, Fyhrquist F: Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun 173: 514-520, 1990
23. Suzuki N, Matsumoto H, Kitada C, Yanagisawa M, Miyauchi T, Masaki T, Fujino M: Immunoreactive endothelin-1 in plasma detected by a sandwich-type enzyme immunoassay. J Cardiovasc Pharmacol 13 (Suppl.5): 151-152, 1989
24. Bloom IT, Bentley FR, Wilson MA, Garrison RN: In vivo effects of endothelin on the renal microcirculation. J Surg Res 54: 274-280, 1993
25. Kurihara T, Akimoto M, Kurokawa K, Ishiguro H, Niimi A, Maeda A, Sigemoto M, Yamashita K, Yokoyama I, Hirayama Y, et al: ET-3 sensitive reduction of tissue blood flow in rat liver. Life Sci 51: 6, 1992
26. Karne S, Jayawickreme CK, Lerner MR: Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J Biol Chem 268: 19126-19133, 1993
27. Terada Y, Tomita K, Nonoguchi H, Marumo F: Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. J Clin Invest 90: 107-112, 1992
28. Lin H, Sangmal M, Smith M, Jr., Young DB: Effect of endothelin-1 on glomerular hydraulic pressure and renin release in dogs. Hypertension 21: 845-851, 1993
29. Sorensen SS, Madsen JK, Pedersen EB: Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am J Physiol 266: F411-F418, 1994
30. Rabelink TJ, Kaasjager KAH, Boer P, Stroes EG, Braam B, Koomans HA: Effects of endothelin-1 on renal function in humans: Implications for physiology and pathophysiology. Kidney Int 46: (in press), 1994
31. Naess PA, Christensen G, Kiil F: Inhibitory effect of endothelin on renin release in dog kidneys. Acta Physiol Scand 148: 131-136, 1993
32. Aramori I, Nirei H, Shoubo M, Sogabe K, Nakamura K, Kojo H, Notsu Y, Ono T, Nakanishi S: Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells. Mol Pharmacol 43: 127-131, 1993
33. Cardell LO, Uddman R, Edvinsson L: A novel ETA-receptor antagonist, FR 139317, inhibits endothelin-induced contractions of guinea-pig pulmonary arteries, but not trachea. Br J Pharmacol 108: 448-452, 1993
34. Sogabe K, Nirei H, Shoubo M, Nomoto A, Ao S, Notsu Y, Ono T: Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. J Pharmacol Exp Ther 264: 1040-1046, 1993
35. Eguchi S, Hirata Y, Ihara M, Yano M, Marumo F: A novel ETA antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. Febs Lett 302: 243-246, 1992
36. Breu V, Loffler BM, Clozel M: In vitro characterization of Ro 46-2005, a novel synthetic nonpeptide endothelin antagonist of ETA and ETB receptors. Febs Lett 334: 210-214, 1993
37. Cristol JP, Warner TD, Thiemermann C, Vane JR: Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br J Pharmacol 108: 776-779, 1993
38. Pollock DM, Opgenorth TJ: Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am J Physiol 264: R222-R226, 1993
39. Seo B, Oemar BS, Siebenmann R, von Segesser L, Lüscher TF: Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89: 1203-1208, 1994
40. Wenzel RR, Noll G, Lüscher TF: Endothelin receptor antagonists inhibit endothelin in human skin microcirculation. Hypertension 23: 581-586, 1994
41. Vanhoutte PM: Is endothelin involved in the pathogenesis of hypertension? Hypertension 21: 747-751, 1993
42. Vierhapper H, Wagner OF, Nowotny P, Waldhausl W: Effect of endothelin-1 in man: pretreatment with nifedipine, with indomethacin and with cyclosporine A. Eur J Clin Invest 22: 55-59, 1992
43. Yokokawa K, Tahara H, Kohno M, Murakawa K, Yasunari K, Nakagawa K, Hamada T, Otani S, Yanagisawa M, Takeda T: Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann Intern Med 114: 213-215, 1991
44. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267: 16066-16068, 1992
45. Suzuki N, Miyauchi T, Tomobe Y, Matsumoto H, Goto K, Masaki T, Fujino M: Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem Biophys Res Commun 167: 941-947, 1990
46. Kitamura K, Tanaka T, Kato J, Ogawa T, Eto T, Tanaka K: Immunoreactive endothelin in rat kidney inner medulla: marked decrease in spontaneously hypertensive rats. Biochem Biophys Res Commun 162: 38-44, 1989
47. Richard V, Hogie M, Clozel M, Loffler BM, Thuillez C: In vivo evidence of an endothelininduced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 91: 771-775, 1995
48. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao W-H, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, Yazaki Y: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703-710, 1994
49. Haynes WG, Webb DJ: Venoconstriction to endothelin-1 in humans: role of calcium and potassium channels. Am J Physiol 265: H1676-H1681, 1993
50. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W, et al.: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365: 759-761, 1993
51. Li JS, Lariviere R, Schiffrin EL: Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Hypertension 24: 183-188, 1994
52. Cernacek P, Stewart DJ: Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 161: 562-567, 1989
53. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328: 1732-1739, 1993
54. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84: 1086-1095, 1989
55. Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, Lüscher TF: Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 70: 1191-1197, 1992
56. Lerman A, Click RL, Narr BJ, Wiesner RH, Krom RA, Textor SC, Burnett JJ: Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation. Transplantation 51: 646-650, 1991
57. Hahn AW, Resink TJ, Kern F, Buhler FR: Peptide vasoconstrictors, vessel structure, and vascular smooth-muscle proliferation. J Cardiovasc Pharmacol 22: Suppl 5: S37-S43, 1993
58. Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS, Yanagisawa M, Masaki T, Sugimoto T: Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83: 476-483, 1991
59. Stewart DJ, Kubac G, Costello KB, Cernacek P: Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18: 38-43, 1991
60. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K: Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89: 1573-1579, 1994
61. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R: Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85: 504-509, 1992
62. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC, Jr.: Endothelin in human congestive heart failure. Circulation 89: 1580-1586, 1994
63. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Ochslin E, Schmidt R, Jones R, Bertel O: Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure. Lancet 346: 732-736, 1995
64. Roubert P, Cornet S, Plas P, Guilmard C, Pirotzky E, Chabrier PE, Braquet P: Upregulation of renal endothelin receptors in glycerol-induced acute renal failure in the rat. J Cardiovasc Pharmacol 22: S303-S305, 1993
65. Tomita K, Ujiie K, Nakanishi T, Tomura S, Matsuda O, Ando K, Shichiri M, Hirata Y, Marumo F: Plasma endothelin levels in patients with acute renal failure [letter]. N Engl J Med 321: 16, 1989
66. Warrens AN, Cassidy MJ, Takahashi K, Ghatei MA, Bloom SR: Endothelin in renal failure. Nephrol Dial Transplant 5: 418-422, 1990
67. Nambi P, Pullen M, Jugus M, Gellai M: Rat kidney endothelin receptors in ischemia-induced acute renal failure. J Pharmacol Exp Ther 264: 345-348, 1993
68. Vemulapalli S, Chiu PJ, Chintala M, Bernardino V: Attenuation of ischemic acute renal failure by phosphoramidon in rats. Pharmacology 47: 188-193, 1993
69. Mino N, Kobayashi M, Nakajima A, Amano H, Shimamoto K, Ishikawa K, Watanabe K, Nishikibe M, Yano M, Ikemoto F: Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol 221: 77-83, 1992
70. Gellai M, Jugus M, Fletcher T, De Wolf R, Nambi P: Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat. J Clin Invest 93: 9006, 1994
71. Mallamaci F, Parlongo S, Zoccali C: Influence of cardiovascular damage and residual renal function on plasma endothelin in chronic renal failure. Nephron 63: 291-295, 1993
72. Heyman SN, Clark BA, Cantley L, Spokes K, Rosen S, Brezis M, Epstein FH: Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radiol 28:313-318, 1993
73. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, Epstein FH: Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 3: 58-65, 1992
74. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH: Role of endothelin and prostaglandins in radio contrast-induced renal artery constriction. Kidney Int 44: 1217-1223, 1993
75. Margulies KB, Hildebrand FL, Heublein DM, Burnett J, Jr.: Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 2: 1041-1045, 1991
76. Heyman SN, Clark BA, Kaiser N, Epstein FH, Spokes K, Rosen S, Brezis M: In-vivo and in vitro studies on the effect of amphotericin B on endothelin release. J Antimicrob Chemother 29: 69-77, 1992
77. Ohta K, Hirata Y, Shichiri M, Ichioka M, Kubota T, Marumo F: Cisplatin-induced urinary endothelin excretion [letter]. Jama 265: 1391-1392, 1991
78. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 43: 354-358, 1993
79. Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 44: 440-444, 1993
80. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992
81. Ross RD, Kalidindi V, Vincent JA, Kassab J, Dabbagh S, Hsu JM, Pinsky WW: Acute changes in endothelin-1 after hemodialysis for chronic renal failure. J Pediatr 122: S74-S76, 1993
82. Deray G, Carayon A, Maistre G, Benhmida M, Masson F, Barthelemy C, Petitclerc T, Jacobs C: Endothelin in chronic renal failure. Nephrol Dial Transplant 7: 300-305, 1992
83. Zamora MR, O'Brien RF, Rutherford RB, Weil JV: Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon [see comments]. Lancet 336: 1144-1147, 1990
84. Fyhrquist F, Saijonmaa O, Metsarinne K, Tikkanen I, Rosenlof K, Tikkanen T: Raised plasma endothelin-I concentration following cold pressor test. Biochem Biophys Res Commun 169: 217-221, 1990
85. Niwa T, Fujishiro T, Uema K, Tsuzuki T, Tominaga Y, Emoto Y, Miyazaki T, Maeda K: Effect of hemodialysis on plasma levels of vasoactive peptides: endothelin, calcitonin gene-related peptide and human atrial natriuretic peptide. Nephron 64: 552-559, 1993
86. Collier A, Leach JP, McLellan A, Jardine A, Morton JJ, Small M: Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 15: 1038-1040, 1992
87. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K: Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome [see comments]. N Engl J Med 327: 1774-1778, 1992
88. Spooren PF, Vermes I, Kip L, Haanen C: Endothelin: a possible role in the occurrence of renal failure in thrombotic thrombocytopenic purpura [letter]. Thromb Haemost 69: 401-432, 1993
89. Morise Z, Ueda M, Aiura K, Endo M, Kitajima M: Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 115: 199-204, 1994
90. Voerman HJ, Stehouwer CD, van Kamp GJ, Strack van Schijndel RJ, Groeneveld AB, Thijs LG: Plasma endothelin levels are increased during septic shock. Crit Care Med 20: 1097-1101, 1992
91. Margulies KB, Hildebrand FJ, Lerman A, Perrella MA, Burnett JJ: Increased endothelin in experimental heart failure. Circulation 82: 2226-2230, 1990
92. Rodeheffer RJ, Lerman A, Heublein DM, Burnett JJ: Increased plasma concentrations of endothelin in congestive heart failure in humans [see comments]. Mayo Clin Proc 67: 719-724, 1992
93. Stewart DJ, Cernacek P, Costello KB, Rouleau JL: Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 85: 510-517, 1992
94. Cavero PG, Miller WL, Heublein DM, Margulies KB, Burnett JJ: Endothelin in experimental congestive heart failure in the anesthetized dog. Am J Physiol Renal Fluid Electrolyte Physiol 259: 28-32, 1990
95. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett n Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325: 997-1001, 1991
96. Nakamura T, Ebihara I, Fukui M, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H: Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZB/W F1 mice. Renal Physiol Biochem 16: 233-243, 1993
97. Ong AC, Jowett TP, Scoble JE, O'Shea JA, Varghese Z, Moorhead JF: Effect of cyclosporin A on endothelin synthesis by cultured human renal cortical epithelial cells. Nephrol Dial Transplant 8: 748-753, 1993
98. Bunchman TE, Brookshire CA: Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 88: 310-314, 1991
99. Iwasaki S, Homma T, Kon V: Site specific regulation in the kidney of endothelin and its receptor subtypes by cyclosporine. Kidney Int 45: 592-597, 1994
100. Copeland KR, Yatscoff RW: Comparison of the effects of cyclosporine and its metabolites on the release of prostacyclin and endothelin from mesangial cells. Transplantation 53: 6405, 1992
101. Moutabarrik A, Ishibashi M, Fukunaga M, Kameoka H, Kawaguchi N, Takano Y, Kokado Y, Sonoda T, Onishi S, Takahara S, et al: FK506-induced kidney tubular cell injury. Transplantation 54: 1041-1047, 1992
102. Lanese DM, Conger JD: Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 91: 2144-2149, 1993
103. Grieff M, Shoheib SA, Lortscher R, Stewart DJ: Cyclosporine A induces elevation in circulationg endothelin-1 following transplantation. J Am Soc Nephrol 1: 758, 1991
104. Kon V, Awazu M: Endothelin and cyclosporine nephrotoxicity. Ren Fail 14: 345-350, 1992
105. Omland T, Terje Lie R, Aakvaag A, Aarsland T, Dickstein K: Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89: 1573-1579, 1994